🌎
Session Report

Myasthenia Gravis Landscape Analysis

Rare Disease — Neurology

Full competitive landscape for myasthenia gravis across US, EU, UK, and Canada. Covers epidemiology, treatment paradigm shifts toward FcRn and C5 inhibitors, regulatory access gaps between regions, reimbursement signals, and near-term competitive pressure from label expansion and seronegative development programmes.

Executive Snapshot Pipeline Tracking Payer Access Evidence Synthesis Multi-Region
🧬
Client-Facing Report

SMA Engagement Landscape & Campaign Plan — Brazil

Rare Disease — Neurology

A client-facing report mapping the Medical Affairs engagement landscape for Spinal Muscular Atrophy in Brazil. Covers newborn screening gaps, regional diagnostic disparities, advocacy partnerships, and KOL network mapping — translated into a non-promotional campaign architecture with tiered evidence, state-level overlay models, and time-boxed next steps.

Evidence Tiering Campaign Architecture KOL Networks State Overlay Model Compliance
📈
C-Suite Brief

Portugal HIV Standard of Care — Executive Decision Brief

Public Health — Infectious Disease

An executive-level strategic brief produced for decision-makers evaluating Portugal's HIV standard of care and system-improvement roadmap. Covers upstream prevention gaps, PrEP delivery fragility, implementation stress signals, and long-acting PrEP readiness — each tied to verified signals with explicit "why it matters" framing.

Executive Summary Verified Signals Policy Analysis Decision Support
📊
Session Summary

HIV Standard of Care — Full Session Intelligence Report

Public Health — Infectious Disease

A comprehensive session summary covering the full lifecycle of a Portugal HIV Standard of Care programme. Tracks landscape analysis through proposal drafting, Monte Carlo multi-plan stress testing, anchor verification, and a v3.0 post-verification sweep — with epidemiology tables, stakeholder maps, deliverables library, and claims discipline improvements.

Monte Carlo Simulation Verification Sweep Stakeholder Map Epidemiology Full Lifecycle
Note: These reports were generated from real sAÏmone sessions using live data sources. All outputs are AI-assisted under GDPR, EMA, and jurisdictional transparency frameworks. They do not constitute legal, medical, or financial advice. Outputs require human validation. Some identifying details may have been adjusted for public presentation.